Diacylglycerol kinase α promotes 3D cancer cell growth and limits drug sensitivity through functional interaction...

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Diacylglycerol kinase alpha (DGKα) is a lipid kinase involved in cancer cell survival, migration, and invasion.
• The specific mechanisms by which DGKα contributes to cancer survival remain unclear.
• DGKα's selective impact on tumor cells suggests its potential as a cancer-specific therapeutic target.

Purpose of the Study:

• To elucidate the mechanisms underlying DGKα's specific contribution to cancer survival.
• To investigate the role of DGKα in regulating Src activation in cancer cells.
• To evaluate the therapeutic potential of targeting DGKα in cancer treatment.

Main Methods:

• Utilized three-dimensional (3D) colon and breast cancer cell cultures.
• Employed pharmacological and genetic silencing of DGKα.
• Assessed tumor growth in vivo.
• Investigated DGKα's role in Src activation and response to inhibitors.

Main Results:

• DGKα upregulation was identified as part of the transcriptional program leading to Src activation in cancer cell cultures.
• Pharmacological or genetic silencing of DGKα impaired tumor growth in vivo.
• DGKα-mediated Src regulation limited the efficacy of Src inhibitors.
• Transcriptional upregulation of DGKα in response to PI3K/Akt inhibitors reduced their toxicity.

Conclusions:

• DGKα stabilizes Src activation, a key mechanism driving tumor growth.
• Targeting DGKα selectively alters tumor viability without affecting untransformed cells.
• Inhibiting DGKα, alone or in combination with other therapies, may offer a treatment strategy for aggressive cancers.